IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis

Schizophrenia and treatment of this disorder are often accompanied with metabolic syndrome and cardiovascular issues. Alterations in the serum level of innate immune mediators, such as interleukin-33 (IL-33) and its receptor IL-33R (ST2) and Galectin-3 (Gal-3) were observed in these conditions. More...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Milica M. Borovcanin, Slavica M. Janicijevic, Ivan P. Jovanovic, Nevena Gajovic, Nebojsa N. Arsenijevic, Miodrag L. Lukic
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2018-06-01
Serija:	Frontiers in Psychiatry
Teme:	schizophrenia galectin-3 interleukin-33 metabolic syndrome cardiovascular issues
Online dostop:	https://www.frontiersin.org/article/10.3389/fpsyt.2018.00271/full
Oznake:	Označite Brez oznak, prvi označite!